Published in J Am Coll Cardiol on January 01, 2000
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Antithrombotic treatment in atrial fibrillation. Heart (2005) 2.00
Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace (2011) 1.58
64-MDCT showed the thrombus in the pulmonary vein of the patient with angina pectoris. BMJ Case Rep (2012) 1.30
Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28
Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis (2009) 1.14
64-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris. BMJ Case Rep (2013) 1.08
Ablation for atrial fibrillation during mitral valve surgery: 1-year results through continuous subcutaneous monitoring. Interact Cardiovasc Thorac Surg (2012) 1.05
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J (2013) 1.03
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study. J Interv Card Electrophysiol (2006) 0.89
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial. BMC Cardiovasc Disord (2013) 0.86
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol (2008) 0.85
Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. J Am Heart Assoc (2015) 0.85
Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study. BMC Public Health (2007) 0.84
Antithrombotic treatment in atrial fibrillation. Heart (2006) 0.84
Stroke risk in AF: do AF patterns matter? Eur Heart J (2010) 0.84
Challenges in the classification of atrial fibrillation. Nat Rev Cardiol (2010) 0.83
Management of atrial fibrillation. Vasc Health Risk Manag (2007) 0.83
Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation. Am J Med (2014) 0.83
Detection of occult atrial fibrillation by pacemaker interrogation in cryptogenic stroke. J Interv Card Electrophysiol (2014) 0.81
Decoding cryptogenic cardioembolism. Ann Neurol (2008) 0.81
Management of atrial fibrillation. Heart (2006) 0.81
[Electrical and pharmacological strategies for early cardioversion of atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2006) 0.81
Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options. J Saudi Heart Assoc (2014) 0.80
Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation? Cardiol Res Pract (2011) 0.79
The D-dimer assay: a possible tool in the evaluation of atrial thrombosis. Can J Cardiol (2008) 0.79
Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke. Can J Hosp Pharm (2013) 0.78
Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants. Arrhythm Electrophysiol Rev (2014) 0.78
Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. Sci Rep (2016) 0.78
Assessment of normal left atrial appendage anatomy and function over gender and ages by dynamic cardiac CT. Eur Radiol (2015) 0.77
Persistent atrial fibrillation is associated with worse prognosis than paroxysmal atrial fibrillation in acute cerebral infarction. ISRN Cardiol (2012) 0.77
Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia? Biomed Res Int (2015) 0.76
Barriers to the use of warfarin: potential solutions. J Interv Card Electrophysiol (2004) 0.76
Correlating hemodynamic magnetic resonance imaging with high-field intracranial vessel wall imaging in stroke. J Radiol Case Rep (2014) 0.76
Stroke: finding atrial fibrillation after cryptogenic stroke. Nat Rev Neurol (2012) 0.75
A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals. BMJ Open (2014) 0.75
Complications From Left Atrial Appendage Exclusion Devices. J Atr Fibrillation (2014) 0.75
Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants. J Blood Med (2012) 0.75
Selecting antithrombotic therapy for patients with atrial fibrillation. Cleve Clin J Med (2015) 0.75
Non-coronary cardiac findings and pitfalls in coronary computed tomography angiography. J Clin Imaging Sci (2011) 0.75
Non-cardioembolic Mechanisms in Cryptogenic Stroke: Clinical and Diffusion-weighted Imaging Features. J Clin Neurol (2005) 0.75
Invasive Management of Atrial Fibrillation and the Elderly. J Atr Fibrillation (2010) 0.75
Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: A nationwide cohort study. Medicine (Baltimore) (2016) 0.75
Atrial high-rate episodes and stroke prevention. Europace (2017) 0.75
Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2015) 0.75
Intermittent atrial fibrillation and stroke. Rev Cardiovasc Med (2000) 0.75
Presence Of Left Atrial Appendage Thrombus In Patients Presenting For Left Atrial Ablation Of Atrial Fibrillation Despite Pre-Operative Anticoagulation. J Atr Fibrillation (2009) 0.75
Imaging pitfalls, normal anatomy, and anatomical variants that can simulate disease on cardiac imaging as demonstrated on multidetector computed tomography. Acta Radiol Short Rep (2015) 0.75
Paroxysmal atrial fibrillation presenting as acute lower limb ischemia. Korean J Fam Med (2011) 0.75
Left atrial appendage dysfunction in acute cerebral embolism patients with sinus rhythm: correlation with pulse wave tissue Doppler imaging. Int J Cardiovasc Imaging (2014) 0.75
The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation: the Vitatron Selection AFm Registry study. J Interv Card Electrophysiol (2010) 0.75
[Antithrombotic therapy in atrial fibrillation: when vitamin K antagonists? When aspirin? When heparin? When combinations of anticoagulant and antiplatelet drugs?]. Herzschrittmacherther Elektrophysiol (2009) 0.75
Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy. Heart Vessels (2015) 0.75
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med (2001) 5.67
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (2013) 5.20
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med (1981) 3.00
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest (2001) 2.72
Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. J Thromb Haemost (2007) 2.72
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J (1999) 2.68
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.01
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol (1998) 1.95
Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol (2001) 1.68
Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke (2002) 1.61
Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. Am J Cardiol (1981) 1.60
Assessment and follow-up of pediatric survivors of sudden cardiac death. Circulation (1990) 1.57
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol (1992) 1.55
Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol (1990) 1.54
The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med (1998) 1.51
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Atrial fibrillation and stroke. Revisiting the dilemmas. Stroke (1994) 1.49
Pathophysiology of Raynaud's disease. Arch Intern Med (1979) 1.47
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation (1984) 1.44
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43
Two-dimensional echocardiographic imaging of left ventricular mural vegetations. Am Heart J (1988) 1.42
Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation (1978) 1.41
Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med (1999) 1.41
Design and clinical application of a low-pass input filter for the evaluation of intracardiac electrograms during radiofrequency catheter ablation. Am J Cardiol (1993) 1.38
Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis (2000) 1.37
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation (1981) 1.35
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2007) 1.33
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 1.33
Progressive myoclonus epilepsy with Lafora inclusion bodies. I. Clinical, genetic, histopathologic, and biochemical aspects. Arch Neurol (1967) 1.32
Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol (1995) 1.31
Atrial fibrillation and stroke : concepts and controversies. Stroke (2001) 1.27
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr (1999) 1.22
An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer (2000) 1.21
Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation (1982) 1.20
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Am Heart J (1981) 1.19
Natural history of "high-risk" bundle-branch block: final report of a prospective study. N Engl J Med (1982) 1.13
Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol (1985) 1.12
Improvement in left ventricular wall motion following nitroglycerin. Circulation (1975) 1.12
Ergonovine-provoked esophageal spasm during coronary angiography. West J Med (1984) 1.09
Epidemiology of syncope in hospitalized patients. J Gen Intern Med (1999) 1.09
Familial hypokalemic periodic paralysis with permanent myopathy. A clinical and ultrastructural study. J Neuropathol Exp Neurol (1967) 1.07
Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng (1997) 1.07
Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol (2001) 1.06
Report of the task force on children and youth. American Heart Association. Circulation (1993) 1.04
Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med (2000) 1.02
Two-dimensional echocardiographic identification of left ventricular pseudoaneurysm. Am Heart J (1986) 1.01
Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions. JAMA (1994) 1.01
Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology (2000) 1.00
Two-dimensional echocardiographic demonstration of left atrial thrombi in patients with prosthetic mitral valves. Circulation (1979) 1.00
Cardiovascular physiology. Clin Obstet Gynecol (1981) 1.00
Indications for echocardiography in patients with ischemic stroke. Neurology (1982) 0.99
Spontaneous changes in left ventricular function between sequential studies. Am J Cardiol (1974) 0.99
Familial spinocerebellar degeneration, hemolytic anemia, and glutathione deficiency. Arch Intern Med (1974) 0.98
Postural heart block. Br Heart J (1980) 0.98
Analysis of local electrogram characteristics correlated with successful radiofrequency catheter ablation of accessory atrioventricular pathways. Pacing Clin Electrophysiol (1992) 0.97
Progressive myoclonus epilepsy with Lafora inclusion bodies. II. Studies of ultrastructure. Arch Neurol (1967) 0.97
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol (1993) 0.97
Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis. Circulation (1982) 0.97
Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. Arch Intern Med (1994) 0.96
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population. J Thromb Haemost (2010) 0.96
Left ventricular thrombi and cerebral embolism. N Engl J Med (1989) 0.95
Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun (1985) 0.95
The prevalence and one-year outcome of limb arterial obstructive disease in a nursing home population. J Am Geriatr Soc (1988) 0.95
Two-dimensional echocardiographic identification of complicated aortic root endocarditis: implications for surgery. J Am Coll Cardiol (1987) 0.95
Recipient to donor conduction of atrial tachycardia following orthotopic heart transplantation. Pacing Clin Electrophysiol (1998) 0.94
Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med (1990) 0.94
Echocardiography in diagnostic assessment of stroke. Ann Intern Med (1981) 0.92
Left ventricular thrombus and stroke after myocardial infarction: toward prevention or perplexity? J Am Coll Cardiol (1989) 0.92
Histamine and spermidine content in brain during development. Science (1969) 0.92
Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol (1990) 0.92
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF. J Clin Pharmacol (2014) 0.91
Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol (1987) 0.91
Amantadine for Parkinson's disease. Neurology (1971) 0.90
A prospective study of sudden death in "high-risk" bundle-branch block. N Engl J Med (1978) 0.89